Lacarya Scott Overview
- Firm
- Tungsten Advisor...
- Primary Position
-
Founding Partner
Lacarya Scott General Information
Biography
Mr. Lacarya Scott is a Founding Partner of Tungsten Advisors. Mr. Lacarya Scott serves as Chief Financial Officer at iPill. He serves as an Advisory Board Member at Municipal Finance & Services. Previously, he served as Acting Chief Executive Officer at the company. He brings experience from academia, hedge funds, and corporate development. Mr. Scott serves as Chief Strategy Officer at Liposeuticals. He also served as President and Chief Operating Officer at Ligandal. He is the Managing Partner, of Tungsten Advisors and has 19 years of experience across life science research, life science buy-side (via Hedge Fund), and transactional execution at biopharmaceutical companies. He began his career at Life Technologies (formerly Invitrogen Corporation) as an associate in the M&A group, working on all aspects of M&A deals totaling $1.5B from target selection, financial analysis, and valuation, to presenting transactions to the Board for final deal approval. After Life Technologies, he worked at Caxton Associates, a $15B global macro and sectorial hedge fund, investing in many public and private biotechnology companies, serving on the Boards of several companies, and arranging exits via strategic sales. One notable exit was the sale of GeminX to Cephalon for $525M, which transaction generated a 4x return over a 3-year holding period. He has also served as VP of Business Development and Corporate Strategy at several other private and public life science companies, such as Mesoblast. While at NYU, He completed his research on (1) serotonin and its role in cell death and suicide; and (2) PPAR-Y and its role in atherosclerosis via macrophage cells. Mr. Scott earned an AB in Biophysics from Princeton University, an MS in Biology and a research focus in Biological Chemistry from New York University, an MS in Engineering Biotechnology from the University of Pennsylvania, and an MBA in Finance from The Wharton School, University of Pennsylvania. He holds the Chartered Financial Analyst (CFA) designation and FINRA licenses: Securities Industry Essentials, Series 79.
Contact Information
Address
- 767 Third Avenue
- 29th Floor
- New York, NY 10017
- United States
Lacarya Scott Positions (3)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
iPill | Company | Chief Financial Officer | Los Angeles, CA | Other Devices and Supplies | |
Liposeuticals | Company | Chief Strategy Officer | Monmouth Junction, NJ | Drug Discovery | |
Tungsten Advisors | Service Provider | Founding Partner | New York, NY | Merchant Bank |
Lacarya Scott Advisory Roles (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Municipal Finance & Services | Company | Advisory Board Member | Washington, DC | Consulting Services (B2B) |
Lacarya Scott FAQs
-
Who is Lacarya Scott?
Mr. Lacarya Scott is a Founding Partner of Tungsten Advisors.
-
How much does Lacarya Scott typically invest?
Lacarya Scott's median deal size is
. -
What is Lacarya Scott’s main position?
Lacarya Scott’s primary position is Founding Partner.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »